Time- and dose-related interactions between glucocorticoid and cyclic adenosine 3′,5′-monophosphate on CCAAT/enhancer-binding protein-dependent insulin-like growth factor I expression by osteoblasts

Endocrinology

Volumn 141, Issue 1, 2000, Pages 127-137

  McCarthy, Thomas L ^a   Ji, Changhua ^a   Chen, Yun ^a   Kim, Kenneth ^a   Centrella, Michael ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; COLLAGEN; CYCLIC AMP; GLUCOCORTICOID; PROSTAGLANDIN E2; SOMATOMEDIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FETUS; GENE ACTIVATION; GENE ACTIVITY; HORMONAL REGULATION; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; RAT;

EID: 0034463019     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.1.7237     Document Type: Article

References (82)

1. Insulin-like growth factor I has independent effects on bone matrix formation and cell replication
2. Regulatory effects of insulin-like growth factor I and II on bone collagen synthesis in rat calvarial cultures
3. Insulin-like growth factor I regulates type I procollagen messenger ribonucleic acid steady state levels in bone of rats
4. Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblastenriched cultures from fetal rat bone
5. 2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone
6. Cyclic AMP induces insulin-like growth factor I synthesis in osteoblast-enriched cultures
7. Regulation of insulin-like growth factor I transcription by cyclic adenosine 3′,5′-monophosphate (cAMP) in fetal rat bone cells through an element within exon 1: Protein kinase A-dependent control without a consensus AMP response element
8. The neuropeptide calcitonin gene related peptide stimulates insulin-like growth factor I production by primary fetal rat osteoblasts
9. Insulin-like growth factor I mediates selective effects of parathyroid hormone in bone cultures
10. Functional analysis of the rat insulin-like growth factor I gene and identification of an IGF-I gene promoter
11. 2 rapidly stimulates insulin-like growth factor I gene expression in primary rat osteoblast cultures: Evidence for transcriptional control
12. 2 in osteoblasts
13. Essential promoter elements are located within the 5′ untranslated region of human insulin-like growth factor-I exon 1
14. CCAAT/enhancer binding protein δ activates insulin-like growth factor-I gene transcription in osteoblasts
15. IL-6 and NF-IL6 in acute-phase response and viral infection
16. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8
17. Regulation of the interleukin-1β (IL-1β) gene by mycobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL6 motifs
18. Autoregulated induction of the acute-phase response transcription factor gene, agp/ebp (C/EBPβ)
19. Molecular responses to hyperoxia in vivo: Relationship to increased tolerance in aged rats
20. Effect of thermal injury on the expression of transcription factors that regulate acute phase response genes: The response of C/EBPα, C/EBPβ, and C/EBPδ to thermal injury
21. Biological role of the CCAAT/enhancer-binding protein family of transcription factors
22. The C/EBP family of transcription factors
23. The role of C/EBP isoforms in the control of inflammatory and native immunity function
24. Corticosteroid-induced osteoporosis
25. Glucocorticoid-induced osteoporosis
26. Cortisol inhibits the synthesis of insulin-like growth factor I in bone cell cultures
27. Transcriptional repression of insulin-like growth factor I by glucocorticoids in rat bone cells
28. Cortisol decreases IGF-I mRNA levels in human osteoblast-like cells
29. Altered parathyroid hormone- or calcitonin-stimulated adenosine 3′,5′-monophosphate release by isolated perfused bone from glucocorticoid-treated rats
30. Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro
31. Determination of the capacity for proliferation and differentiation of osteoprogenitor cells in the presence and absence of dexamethasone
32. Long-term effects of physiologic concentrations of dexamethasone on human bone-derived cells
33. 2 on bone formation in cultured fetal rat calvariae: Role of insulin-like growth factor-I
34. Modulation of the effects of glucocorticoids on collagen synthesis in fetal rat calvariae by insulin-like growth factor binding protein-2
35. Mitogenesis in fetal rat bone cells simultaneously exposed to transforming growth factor β and other growth regulators
36. Further biochemical and molecular characterization of primary rat parietal bone cell cultures
37. Parathyroid hormone-related protein modulates the effects of transforming growth factor-β on deoxyribonucleic acid and collagen synthesis in fetal rat bone cells
38. Differential actions of prostaglandins in separate cell populations from fetal rat bone
39. Independent changes in type I and type II receptors for transforming growth factor β induced by bone morphogenetic protein-2 parallel expression of the osteoblast phenotype
40. Changes in bone morphogenetic protein sensitivity relative to differentiation in fetal rat bone cell cultures
41. Expression of cell growth and bone specific genes at single cell resolution during development of bone tissue-like organization in primary osteoblast cultures
42. The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro
43. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
44. Characterization of the polypeptide composition of human factor VIII:C and the nucleotide sequence and expression of the human kidney cDNA
45. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
46. A small scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing
47. CCAAT/enhancer binding protein δ is a critical regulator of insulin-like growth factor-I gene transcription in osteoblasts
48. Selective and early increase in IL-1 inhibitors, IL-6 and cortisol after elective surgery
49. The management of acute bone loss in severe catabolism due to burn injury
50. Metabolic changes observed in astronauts
51. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol
52. Strenuous exercise: Analogous to the acute-phase response?
53. Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase
54. Effects of parathyroid hormone and agonists of the adenylylcyclase and protein kinase C pathways on bone cell proliferation
55. Transcriptional roles of nuclear factor κB and nuclear factor-interleukin-6 in tumor necrosis factor α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells
56. Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein
57. Transcription factor C/EBPδ in fetal lung: Developmental regulation and effects of cyclic 3′,5′-monophosphate and glucocorticoids
58. Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes
59. The role of C/EBP genes in adipocyte differentiation
60. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins
61. The two C/EBP isoforms, IL-6DBP/NF-IL6 and C/EBPδ/NF-IL-6β, are induced by IL-6 to promote acute phase gene transcription via different mechanisms
62. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6
63. Altered adenosine 3′,5′-monophosphate release in response to parathyroid hormone by isolated perfused bone from glucocorticoid-treated dogs
64. The effect of dexamethasone on parathyroid hormone stimulation of adenylate cyclase in ROS 17/2.8 cells
65. 1,25-Dihydroxycholecalciferol and glucocoritcoid regulation of adenylate cyclase in an osteoblast-like cell line
66. Increase of adenylate cyclase catalytic-unit activity by dexamethasone in rat osteoblast-like cells
67. 3 regulate parathyroid hormone stimulation of adenosine 3′,5′-monophosphate-dependent protein kinase in rat osteosarcoma cells
68. Glucocorticoid and 1,25-dihydroxyvitamin D modulate the degree of adenosine 3′,5′-monophosphate-dependent protein kinase isoenzyme I and II activation by parathyroid hormone in rat osteosarcoma cells
69. 1,25-Dihy dorxyvitamin D reduces parathyroid hormone receptor number in ROS 17/2.8 cells and prevents the glucocorticoid-induced increase in these receptors: Relationship to adenylate cyclase activation
70. 2 in osteoblast-like cells
71. 3, and protein kinase C
72. Cortisone-induced osteoporosis: Effects on bone adenylate cyclase
73. Glucocorticoids enhance intracellular signaling via adenylate cyclase at three distinct loci in the fetus: A mechanism for heterologous teratogenic sensitization?
74. Age-related expression of osteoblast phenotypic markers in normal human osteoblasts cultured long-term in the presence of dexamethasone
75. Regulation of parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acid by glucocoticoids and PTH in ROS 17/2.8 and OK cells
76. Dexamethasone enhances the effects of parathyroid hormone on human periodontal ligment cells in vitro
77. Dexamethasone-induced haptoglobin release by calf liver parenchymal cells
78. Phosphorylation of immunopurified rat liver glucocorticoid receptor by the catalytic subunit of cAMP-dependent protein kinase
79. Modulation of cell signaling pathways can enhance or impair glucocorticoid-induced gene expression without altering the state of receptor phosphorylation
80. cAMP modulates glucocorticoid-induced protein accumulation and glucocorticoid receptor in cardiomyocytes
81. The glucocorticoid-response gene cascade. Activation of the rat arginase gene through induction of C/EBPβ
82. AF-2-dependent potentiation of CCAAT/enhancer binding protein beta-mediated transcriptional activation by glucocorticoid receptor